背阔肌肌皮瓣联合硅胶假体即刻乳房重建后辅助放疗对乳腺癌的影响
本研究回顾性分析了176例接受背阔肌肌皮瓣联合硅胶假体即刻乳房重建的乳腺癌患者,56.3%术后接受辅助放疗。中位随访58.1个月,31.8%发生包膜挛缩,辅助放疗与包膜挛缩(OR 7.38)及植入物相关再手术(风险为对照的2.84倍)风险升高相关,但重建失败率低。
要点
- 辅助放疗使包膜挛缩风险显著升高(OR 7.38,95%CI 3.18-17.10,P<0.001)。
- 手术时间延长(超过均值1个标准差)与包膜挛缩风险升高相关(OR 4.72)。
- 接受辅助放疗者发生重建失败或植入物相关再手术的风险为未放疗者的2.84倍(P=0.002)。
核心结论
- 背阔肌肌皮瓣联合硅胶假体即刻乳房重建后辅助放疗是安全的手术方式,重建失败率低;但辅助放疗增加包膜挛缩发生和植入物相关再手术的可能性,对重建乳房有负面影响。
研究设计与样本
- 回顾性收集并分析176例接受背阔肌肌皮瓣联合硅胶假体即刻乳房重建患者的临床、手术和肿瘤学资料。
主要发现
- 7.4%的患者有既往放疗史,56.3%接受了辅助放疗,平均随访58.1个月,31.8%发生包膜挛缩。
- 14.2%的手术被归类为手术时间延长(超过观察均值的1个标准差)。
- 手术时间延长者发生包膜挛缩的OR为4.72(95%CI 1.72-12.93,P=0.003)。
- 接受辅助放疗者发生包膜挛缩的OR为7.38(95%CI 3.18-17.10,P<0.001)。
- 32例(18%)行包膜切除术并更换假体,7例(4%)取出假体;从即刻乳房重建到再手术的平均时间为29.1个月;接受辅助放疗者发生重建失败或植入物相关再手术的风险为未放疗者的2.84倍(P=0.002)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: About 30% to 50% of women with breast cancer undergo mastectomy, and approximately 50% of them will receive adjuvant radiotherapy (ART). This study evaluates the medium- and long-term impact of ART after immediate breast reconstruction (IBR) with latissimus dorsi myocutaneous (LDM) flap and silicone implants. METHODS: Clinical, surgical, and oncological data were retrospectively collected and analyzed based on the medical records of 176 patients who had undergone IBR with LDM flap and silicone implants. RESULTS: The data showed that 7.4% of patients had a history of previous radiotherapy, 56.3% received ART, 31.8% developed capsular contracture with a mean follow-up of 58.1 months, and 14.2% of surgeries were categorized as procedures with a prolonged operating time, lasting above 1 SD of the observed mean. Those who experienced prolonged operating time (odds ratio, 4.72; 95% confidence interval, 1.72-12.93; P = 0.003) and those who received ART (odds ratio, 7.38; 95% confidence interval, 3.18-17.10; P < 0.001) were more likely to develop capsular contracture. Thirty-two patients (18%) underwent capsulectomy with implant replacement, and 7 patients (4%) had the implant removed. The mean time between IBR and reoperation was 29.1 months. Patients who received ART were 2.84 times more likely to experience reconstruction failure or undergo implant-related reoperation ( P = 0.002). CONCLUSIONS: The results indicated that IBR with LDM flap and silicone implant followed by ART is a safe procedure, resulting in low rates of reconstruction failure. However, ART increased the likelihood of capsular contracture development and implant-related reoperation, having a negative effect on reconstructed breasts.
引用
- D'Alessandro GS, Munhoz AM, Takeuchi FM, et al. Immediate Breast Reconstruction With Latissimus Dorsi Myocutaneous Flap and Silicone Implant Followed by Adjuvant Radiotherapy for Breast Cancer. Ann Plast Surg. 2024. PMID: 38718327. doi:10.1097/SAP.0000000000003882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。